VETERINARY
DIAGNOSTICS
866.647.2847

American College of Chest Physicians Boston, MA October 6-9, 2024

Feb 29, 2024 | News

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT. This event will bring you the most up-to-date education in clinical pulmonary, critical care, and sleep medicine with world-class speakers, hands-on simulation opportunities, interactive educational games, and so much...

ID WEEK Los Angeles, CA October 16-20, 2024

Feb 29, 2024 | News

MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s tailored to your essential role and attend sessions addressing ID’s most pressing challenges....

MiraVista Institutional Biosafety Committee (IBC) Announcement

May 11, 2023 | News

In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure...

Pulmonary Histoplasmosis: A Clinical Update – Published

Feb 10, 2023 | News

MiraVista Diagnostics’ article “Pulmonary Histoplasmosis: A Clinical Update” has been published in “Journal of Fungi” as part of the Special Issue “Diagnosis and Treatment of Invasive Pulmonary Fungal Infections.” Read the...

Only Available at MiraVista Diagnostics: MycoMEIA® Aspergillus Galf Urine EIA
MiraVista Diagnostics now offers MycoMEIA® Aspergillus Galf Urine EIA, a urine-based antigen assay that complements serum galactomannan (GM) testing and may improve diagnostic confidence for invasive aspergillosis (IA).

Learn More
X